Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is Chief of Clinical Trials, Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Centre Tom Powles is Director of Barts Cancer Centre, St Bartholomews Hospital and Professor or Genitourinary oncology, Queen Mary University of London
…
continue reading
Experts at Queen Mary University of London
…
continue reading
This is a podcast from the Centre for the History of Emotions at Queen Mary, University of London. 'The Sound of Anger' won two gold British Podcast Awards in 2020. Subscribe on Apple Podcasts via iTunes here: https://itunes.apple.com/gb/podcast/living-with-feeling/id1186251350?mt=2
…
continue reading
Magic comes to Mile End with Brent Morris, Arthur Benjamin and Colm Mulcahy.
…
continue reading
Queen Mary, University of London is one of the UK's leading research-focused higher education institutions. With around 16,900 students and 3,800 staff, we are one of the biggest University of London colleges. We teach and research across a wide range of subjects in the humanities, social sciences, law, medicine and dentistry, and science and engineering. Based in a creative and culturally diverse area of east London, we are the only London university able to offer a completely integrated re ...
…
continue reading
Experts on Camera
…
continue reading
Stage left podcast explores performers' approaches to making their work. I teach and write about contemporary theatre and performance at Queen Mary University of London.
…
continue reading
Young journalists from The Print (the student newspaper of Queen Mary University of London), discuss issues affecting students in this podcast.
…
continue reading
Internal launch of the life sciences initiative
…
continue reading
1
David Willetts MP, Inaugural John Ramsden Memorial Lecture: Liberal Conservatism
Queen Mary, University of London
What can Liberal Conservatism do for you? The Seventy-Sixth Mile End Group event was given by David Willetts MP on the nature of Liberal Conservatism. David Linsay Willetts (born 9 March 1956) is a British Conservative Party politician and the Minister of State for Universities and Science. He is the Member of Parliament (MP) representing the constituency of Havant in Hampshire. This memorial lecture is a tribute to the life and work of John Ramsden, an eminent historian, politician and memb ...
…
continue reading
1
Professor Joseph Nye, The 2nd Michael Quinlan Lecture: What is Ethical Foreign Policy Leadership?
Queen Mary, University of London
How can we decide what is appropriate in the sphere of global politics? Prof. Joseph Nye, eminent academic, author, and politician with expertise in the field of foreign policy, defense, diplomacy and terrorism talks about his experiences within foreign policy and how he has come to his conclusions using examples like the Iraq war and nuclear weapons. For more information go to www.meg.qmul.ac.uk.
…
continue reading
…
continue reading
SEBASTIAN COTOFANA, M.D., Ph.D., Ph.D. is a professor of anatomy and trauma surgeon based in the United States. He is also an honorary professor at Pirogov University, Moscow, Russia, and holds visiting professorships at the University of Belgrade, Belgarde, Serbia, and Queen Mary University, London, England. Member of the Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands, and Centre for Cutaneous Research, Blizard Institute, Queen Mary University of Lo ...
…
continue reading
What makes a prolific political figure tick? Alastair John Campbell (born 25 May 1957) is a British journalist, broadcaster, political aide and author, best known for his work as Director of Communications and Strategy for Prime Minister Tony Blair between 1997 and 2003. In this interview from 20th June at Mile End Group, Alastair explores his recent autobiography, recounting the key parts of his, and Tony Blair's, career in politics, from the Iraq war to 9/11, and even the Premier's relatio ...
…
continue reading
1
Today's Neuroscience, Tomorrow's History - Professor Geoffrey Burnstock
Professor Geoffrey Burnstock
Supported by a Wellcome Trust Public Engagement grant (2006-2008) in the History of Medicine to Professor Tilli Tansey (QMUL) and Professor Leslie Iversen (Oxford), the History of Modern Biomedicine Research Group at Queen Mary, University of London presents a series of podcasts on the history of neuroscience featuring eminent people in the field: Professor Burnstock returned to London in 1975, becoming Head of Department of Anatomy and Developmental Biology at University College London and ...
…
continue reading
Supported by a Wellcome Trust Public Engagement grant (2006-2008) in the History of Medicine to Professor Tilli Tansey (QMUL) and Professor Leslie Iversen (Oxford), the History of Modern Biomedicine Research Group at Queen Mary, University of London presents a series of podcasts on the history of neuroscience featuring eminent people in the field: Professor Roger Ordidge studied physics at the University of Nottingham, and went on to obtain his PhD in 1981 under the supervision of Professor ...
…
continue reading
Strategies for Bending Time in Music
…
continue reading
Professor Jack Cuzick discusses IBIS-I breast cancer research
…
continue reading
1
Study undergraduate medicine in Malta with a top UK medical school
Queen Mary University of London
…
continue reading
1
Today's Neuroscience, Tomorrow's History - Professor Elizabeth Warrington
Professor Elizabeth Warrington
Supported by a Wellcome Trust Public Engagement grant (2006-2008) in the History of Medicine to Professor Tilli Tansey (QMUL) and Professor Leslie Iversen (Oxford), the History of Modern Biomedicine Research Group at Queen Mary, University of London presents a series of podcasts on the history of neuroscience featuring eminent people in the field: Professor Elizabeth Warrington completed her PhD on visual processing at the Institute of Neurology, London, and was formerly head of the Departme ...
…
continue reading
In this video, we see that mice that are given toys and placed in stimulating surroundings have healthier immune systems.
…
continue reading
📡 EURO—VISION 🛰 the podcast. A series of weekly podcasts that compile conversations with activists, scholars, fisherpeople and artists, hosted by FRAUD, around the politics of extraction, migration and international agreements that are affecting communities and ecologies on a global scale and that perpetuate European colonial legacies. Speakers include: 📢 Prof. Adekeye Adebajo, Director of the Institute for Pan-African Thought and Conversation at the University of Johannesburg, South Africa. ...
…
continue reading
1
Episode 311: The Uromigos Paper of the Month - The POUT Trial
36:02
36:02
Play later
Play later
Lists
Like
Liked
36:02
Alison Birtle describes adjuvant chemotherapy in bladder cancer.
…
continue reading
1
Episode 310: Dosing and duration of drugs from a cost perspective
28:28
28:28
Play later
Play later
Lists
Like
Liked
28:28
Daniel Goldstein describes his work on this issue.
…
continue reading
1
Episode 309: EAU24 Checkmate 274 - OS for adjuvant nivolumab in bladder cancer
27:13
27:13
Play later
Play later
Lists
Like
Liked
27:13
In this second part, Matt Galsky describes the OS signal data. We also look into the future.
…
continue reading
1
Episode 308: EAU24 IMVIGOR 011 - Outcome of ctDNA negative patients post-cystectomy
23:09
23:09
Play later
Play later
Lists
Like
Liked
23:09
Tom, Brian and Matt Galsky review the screening component of this study, presented at EAU24.
…
continue reading
1
Episode 307: Bladder-Sparing Approaches Part 2
35:14
35:14
Play later
Play later
Lists
Like
Liked
35:14
Michiel Van der Heijden explores the role of radiotherapy and other neoadjuvant and other neoadjuvant combinations to prevent the need for surgery.
…
continue reading
1
Episode 306: The Uromigos Paper of the Month - Chemo/Nivo as a bladder sparing approach in UC
29:56
29:56
Play later
Play later
Lists
Like
Liked
29:56
Matt Galsky describes his phase 2 study looking at gem/cis/nivo followed by nivo in responders. This potentially avoids cystectomy.
…
continue reading
1
Episode 305: FDA and Oncology Clinical Trials
29:35
29:35
Play later
Play later
Lists
Like
Liked
29:35
FDA Deputy Oncology Director Dan Suzman described approaches to oncology trials. Tom asks 3 last questions which annoys Brian more than usual.
…
continue reading
1
Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC
30:43
30:43
Play later
Play later
Lists
Like
Liked
30:43
Tanya Dorff describes acapatamab, a prostate-specific membrane antigen (PSMA) CD3 bispecific engager.
…
continue reading
Michael Lattanzi discusses treatment plans and research in the community.
…
continue reading
1
Episode 302: Part 2- Adjuvant Therapy in solid tumors
34:37
34:37
Play later
Play later
Lists
Like
Liked
34:37
Hans Hammers discusses trial design and patient selection in the adjuvant setting.
…
continue reading
1
Episode 301: Cancer research from a global perspective.
31:06
31:06
Play later
Play later
Lists
Like
Liked
31:06
Vania Wisdom, editor of the Lancet, talks about approaches to cancer treatment and research in developing countries
…
continue reading
A series of short podcasts on different emotions, made with researchers from the Queen Mary Centre for the History of the Emotions. These podcasts were commissioned as part of a Wellcome Trust funded research project, 'Living With Feeling: Emotional Health in History, Philosophy, and Experience', and were produced by Natalie Steed.…
…
continue reading
A series of short podcasts on different emotions, made with researchers from the Queen Mary Centre for the History of the Emotions. These podcasts were commissioned as part of a Wellcome Trust funded research project, 'Living With Feeling: Emotional Health in History, Philosophy, and Experience', and were produced by Natalie Steed.…
…
continue reading
A series of short podcasts on different emotions, made with researchers from the Queen Mary Centre for the History of the Emotions. These podcasts were commissioned as part of a Wellcome Trust funded research project, 'Living With Feeling: Emotional Health in History, Philosophy, and Experience', and were produced by Natalie Steed.…
…
continue reading
A series of short podcasts on different emotions, made with researchers from the Queen Mary Centre for the History of the Emotions. These podcasts were commissioned as part of a Wellcome Trust funded research project, 'Living With Feeling: Emotional Health in History, Philosophy, and Experience', and were produced by Natalie Steed.…
…
continue reading
1
Episode 300: Adjuvant PD1 Therapy in Solid Tumours
42:15
42:15
Play later
Play later
Lists
Like
Liked
42:15
David McDermott discusses melanoma and renal data. We never get to bladder or lung.
…
continue reading
1
Episode 299: Androgen receptor ligand-directed degrader BMS-986365
36:40
36:40
Play later
Play later
Lists
Like
Liked
36:40
Dana Rathkopf describes phase 1 data for the androgen receptor ligand-directed degrader in prostate cancer
…
continue reading
Silke, Tom and Brian cover the bases.
…
continue reading
1
Episode 297: ASCO GU 2024: CONTACT2 Part 2 - The Aftermath
22:46
22:46
Play later
Play later
Lists
Like
Liked
22:46
Neeraj Agarwal addresses the issues raised at the meeting.
…
continue reading
1
Episode 296: ASCO GU 2024: Novel approaches to QOL and belzutifan
23:58
23:58
Play later
Play later
Lists
Like
Liked
23:58
Cris Bergerot describes her modifications of existing QOL models while Tom describes the QOL data from LS005
…
continue reading
1
Episode 295: ASCO GU 2024: Adjuvant Therapy in Renal Cancer
32:46
32:46
Play later
Play later
Lists
Like
Liked
32:46
Pedro Barata summarises his ASCO GU discussion on this topic.
…
continue reading
1
Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer
33:17
33:17
Play later
Play later
Lists
Like
Liked
33:17
Andrea Apolo describes the results of this positive trial.
…
continue reading
1
Episode 293: ASCO GU 2024: BRCAaway and CONTACT2
22:21
22:21
Play later
Play later
Lists
Like
Liked
22:21
Kim Chi discussed the prostate cancer oral session at ASCO GU 2024.
…
continue reading
1
Episode 292: ASCO GU 2024: HPN328 - A Tri-Specific T Cell Engager in Prostate Cancer
26:04
26:04
Play later
Play later
Lists
Like
Liked
26:04
Misha Beltran describes the activity of this novel agent in neuroendocrine prostate cancer.
…
continue reading
1
Episode 291: ASCO GU 2024: CONTACT2 - Cabozantinib and Atezolizumab in Prostate Cancer
31:15
31:15
Play later
Play later
Lists
Like
Liked
31:15
Neeraj Agarwal describes the results of this positive randomised Phase 3 trial.
…
continue reading
What to look out for in bladder, prostate and renal cancer at this year's meeting.
…
continue reading
1
Episode 289: The Uromigos Paper of the Month - TALAPRO2 in Nature Medicine
36:02
36:02
Play later
Play later
Lists
Like
Liked
36:02
Karim Fizazi discusses the clinical and biomarker components of this data.
…
continue reading
1
Episode 288: APCCC #3: Controversies around Radiotherapy
36:29
36:29
Play later
Play later
Lists
Like
Liked
36:29
Thomas Zilli discusses controversies around radiotherapy in prostate cancer.
…
continue reading
1
Episode 287 APCCC: Early Discontinuation of Therapy in HSPC
34:48
34:48
Play later
Play later
Lists
Like
Liked
34:48
Silke Gillessen and Betrand Tombal discuss the questions which will address this issue in Lugano in March 2024.
…
continue reading
1
Episode 286: APCCC Prostate Cancer Meeting Overview
30:22
30:22
Play later
Play later
Lists
Like
Liked
30:22
Silke Gillessen discusses this biannual meeting taking place in Lugano in March 2024.
…
continue reading
1
Episode 285: Holiday Special: Renal Cancer in 2023
26:02
26:02
Play later
Play later
Lists
Like
Liked
26:02
Cristina Suarez discusses the year in review.
…
continue reading
1
Episode 284: Tres amigas: Lo más destacado del cáncer en urología en 2023
37:56
37:56
Play later
Play later
Lists
Like
Liked
37:56
Elena Castro, Begoña Valerrama y Cristina Suárez analizan lo más destacado del cáncer en urología en 2023
…
continue reading
1
Episode 283: Holiday Special: Prostate Cancer in 2023
34:34
34:34
Play later
Play later
Lists
Like
Liked
34:34
Tanya Dorff discusses her favourite prostate cancer studies of the year.
…
continue reading
1
Episode 282: Holiday Special: Bladder Cancer in 2023
38:12
38:12
Play later
Play later
Lists
Like
Liked
38:12
Kala Sridhar discusses all the key trials in 2023. She also reveals her favourite Xmas song.
…
continue reading
1
Episode 281: The Uromigos Paper of the Month - Lu-177 with Pembrolizumab in Prostate Cancer
25:23
25:23
Play later
Play later
Lists
Like
Liked
25:23
Rahul Aggarwal describes his phase 1/2 study with only 1 cycle of Lu-177 in CRPC.
…
continue reading
Tian Zhang discusses this fabulous renal cancer meeting. Belzutifan is covered too.
…
continue reading
Tom and Brian apologise for the unacceptable words and images which were broadcast by hackers during the Uromigos livestream last week. We’re really sorry and will do everything we can to make sure it never happens again.
…
continue reading
1
Episode 279: Management of IO-resistant RCC at #UromigosLive 2023
1:00:37
1:00:37
Play later
Play later
Lists
Like
Liked
1:00:37
Monty Pal, Toni Chouieri, and Tian Zhang join Tom and Brian to discuss CONTACT-03, TiNivo-2, IO-based therapy, and more.Recorded live at Uromigos Live & Unplugged 2023 in Nashville, TN.
…
continue reading
1
Episode 278: Current and Future Status of Radioligand Therapy at #UromigosLive 2023
39:31
39:31
Play later
Play later
Lists
Like
Liked
39:31
Brian is joined by Neeraj Agarwal, Tanya Dorff, Rana McKay, and Michael Morris to review the state of radioligand therapy. The panel examines primary and secondary end points of VISION, current practice patterns, the right way to dose 177Lu-PSMA, PSMAfore, and more.Recorded live at Uromigos Live & Unplugged 2023 in Nashville, TN.…
…
continue reading
1
Episode 277: NMIBC Discussion at #UromigosLive 2023
44:04
44:04
Play later
Play later
Lists
Like
Liked
44:04
Tom is joined by Sam Chang, Sia Daneshmand, and Petros Grivas to discuss new therapies in non-muscle invasive bladder cancer, including those for BCG-refractory NMIBC and the cretostimogene + pembrolizumab combo for BCG-unresponsive NMIBC. Recorded live at Uromigos Live & Unplugged 2023 in Nashville, TN.…
…
continue reading
Silke Gillessen joins Tom and Brian to give a summary of the meeting,
…
continue reading
1
Episode 275: Live meeting preview for #UromigosLive 2023 in Nashville
13:30
13:30
Play later
Play later
Lists
Like
Liked
13:30
Brian and Tom discuss the benefits and risks of participating in the upcoming meeting . Uncertainty around it’s success are highlighted . Methods of attending remain opaque.
…
continue reading
1
Episode 274: ESMO 2023 STEAP1/BiTE in CRPC shows promise
19:46
19:46
Play later
Play later
Lists
Like
Liked
19:46
Kevin Kelly described a Six-transmembrane epithelial antigen of the prostate 1 (STEAP1) bispecific T cell engager showing activity in a phase 1 trial in prostate cancer.
…
continue reading
1
Episode 273: ESMO 2023 - Toripalimab and axitinib in clear cell RCC
13:47
13:47
Play later
Play later
Lists
Like
Liked
13:47
Toripalimab plus axitinib as first-line treatment option for advanced RCC by Xinan Sheng
…
continue reading
1
Episode 272: ESMO 2023 - EV302 and CM901 in 1st line bladder cancer
31:32
31:32
Play later
Play later
Lists
Like
Liked
31:32
Michiel van der Heijden and Tom discuss EV302 (EVP) and CM901 (chemo/nivo)
…
continue reading
1
Episode 271: ESMO 2023 - THOR: Erdafitinib in bladder cancer
23:30
23:30
Play later
Play later
Lists
Like
Liked
23:30
Yohann Loriot described the 2 Thor randomised phase 3 studies
…
continue reading
1
Episode 270: ESMO 2023 - Belzutifan in renal cancer
28:26
28:26
Play later
Play later
Lists
Like
Liked
28:26
Lisa Pickering discusses the 2 randomised trial and the 1st line combination study in renal cancer
…
continue reading
1
Episode 269: ESMO 2023 - antibody drug conjugate doublets in UC
24:52
24:52
Play later
Play later
Lists
Like
Liked
24:52
Brad McGregor discuses the DAD trial exploring this combo for the 1st time
…
continue reading
1
Episode 268: ESMO 2023 - Enzalutamide and 177Lu-PSMA-617 in CRPC with Louise Emmett
27:06
27:06
Play later
Play later
Lists
Like
Liked
27:06
Enzalutamide and 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer (mCRPC): A randomised, phase II trial: ENZA-p (ANZUP 1901)
…
continue reading
1
Episode 267: ESMO preview - things to look out for at the meeting
27:05
27:05
Play later
Play later
Lists
Like
Liked
27:05
Silke Gillessen, Brian and Tom look at ESMO 2023 GU track and beyond
…
continue reading